Bibliographic Details
| Title: |
1645P A phase Ib study to evaluate the safety, tolerability and efficacy of the combination of encorafenib, binimetinib and palbociclib in patients with BRAF-mutant metastatic melanoma (CELEBRATE). |
| Authors: |
Chan, J.1 (AUTHOR), Dixon Douglas, J.R.1 (AUTHOR), Xie, J.2 (AUTHOR), Khoo, C.1 (AUTHOR), Soon, J.1 (AUTHOR), Weppler, A.1 (AUTHOR), Parente, P.3 (AUTHOR), Shackleton, M.4 (AUTHOR), Kee, D.5 (AUTHOR), McArthur, G.1 (AUTHOR) |
| Source: |
Annals of Oncology. 2025 Supplement 2, Vol. 36, pS976-S976. 1p. |
| Database: |
Academic Search Ultimate |
